Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Inhibitors of Bacterial Protein Synthesis

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...

Inhibitors of Bacterial DNA Synthesis

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...

Pharmacokinetics: Drug–Drug Interactions

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dental prosthesis use and subsequent functional capacity decline among older adults: a three-year cohort study based on self-reported measures from the JAGES.

Frontiers in oral health·2026

Same author

Reduced Posterior Occlusal Contacts Are Associated With an Increased Risk of Stroke: A Retrospective Study Based on a Japanese Claims Database.

Journal of the American Heart Association·2026

Same author

Impact of leaving periodontal disease untreated on healthcare expenditures: A retrospective cohort study.

Journal of periodontology·2026

Same author

Loss of Posterior Occlusal Support Is Associated With Incident Steatotic Liver Disease in a Nationwide Longitudinal Analysis of the JMDC Claims Database.

Hepatology research : the official journal of the Japan Society of Hepatology·2026

Same author

Impacts of cost-sharing rate increment on the expenditure of outpatient care among older adults: quasi-experimental study of cost-sharing reform in Japan.

BMC health services research·2026

Same author

Impact of explicit fluoride-related language in prefectural dental health ordinance on fluoride mouth-rinse programs dissemination in Japan: a quasi-experimental study.

Frontiers in oral health·2026

Search research articles

Related Experiment Video

Updated: May 8, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

[Syk inhibitors].

Yukihiro Kimura¹, Kazuyasu Chihara, Kenji Takeuchi

¹Division of Genome Science and Microbiology, School of Medicine, University of Fukui.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|August 22, 2013

Summary

This summary is machine-generated.

Spleen tyrosine kinase (Syk) is crucial for immune cells and linked to retinoblastoma. Novel Syk inhibitors show promise for treating inflammatory diseases and thrombocytopenic purpura.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Related Experiment Videos

Last Updated: May 8, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Area of Science:

Biochemistry
Immunology
Molecular Biology

Background:

Spleen tyrosine kinase (Syk) is a non-receptor protein-tyrosine kinase discovered in 1991.
Syk plays essential roles in hematopoietic lineage cells and is implicated in retinoblastoma development.
Recent advancements include the development of novel Syk inhibitors for various therapeutic applications.

Purpose of the Study:

To review the history, structure, and function of Syk.
To discuss the current status and development of novel Syk inhibitors.
To introduce adaptor protein 3BP2 as a novel Syk target.

Main Methods:

Literature review of Syk history, structure, and function.
Analysis of recent studies on Syk inhibitors and their therapeutic evaluations.
Presentation of findings on the interaction between Syk and adaptor protein 3BP2.

Main Results:

Syk is vital for physiological functions, particularly in immune cells.
Ectopic Syk expression is associated with retinoblastoma.
Novel Syk inhibitors are being evaluated for allergic rhinitis, rheumatoid arthritis, and idiopathic thrombocytopenic purpura.

Conclusions:

Syk is a significant kinase with diverse physiological roles.
Targeting Syk with novel inhibitors offers potential therapeutic strategies for immune-related disorders.
Adaptor protein 3BP2 represents a newly identified target for Syk-mediated pathways.